Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B. Biffi R, et al. Among authors: de lucia f, de braud f. Eur J Cancer. 1997 Jul;33(8):1190-4. doi: 10.1016/s0959-8049(97)00039-7. Eur J Cancer. 1997. PMID: 9301441 Clinical Trial.
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
Nolè F, de Braud F, Aapro M, Minchella I, De Pas TM, Zampino MG, Monti S, Andreoni G, Goldhirsch A. Nolè F, et al. Among authors: de pas tm, de braud f. Ann Oncol. 1997 Sep;8(9):865-70. doi: 10.1023/a:1008209429204. Ann Oncol. 1997. PMID: 9358936 Free article. Clinical Trial.
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
Orlando L, Colleoni M, Nolè F, Biffi R, Rocca A, Curigliano G, Ferretti G, Peruzzotti G, de Braud F, Masci G, Goldhirsch A. Orlando L, et al. Among authors: de braud f. Ann Oncol. 2000 Jan;11(1):117-8. doi: 10.1023/a:1008364801718. Ann Oncol. 2000. PMID: 10690401 Free article. No abstract available.
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.
Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, De Cicco C, Mäcke HR, Chinol M, de Braud F. Paganelli G, et al. Among authors: de cicco c, de braud f. Eur J Nucl Med. 2001 Apr;28(4):426-34. doi: 10.1007/s002590100490. Eur J Nucl Med. 2001. PMID: 11357492 Clinical Trial.
683 results